In caring for patients with chronic kidney disease, it is important to prevent and treat hyperphosphatemia with a combination of dietary restrictions and phosphorus binders. This post reviews the availability, cost, side effects and scenarios in which one class of binder may be more beneficial than another.
Why does kidney disease disproportionately affect minorities? What is the connection between renal disease, diabetes and hypertension? These are some of the issues Cleveland Clinic renal disease researchers are pursuing.
Cleveland Clinic research finds that chronic kidney disease is widely prevalent in patients with pulmonary hypertension, and that lower levels of kidney function are associated with an increased risk of death.
Despite higher rates of kidney failure, African-Americans do not have the same access to kidney transplants as Caucasian-Americans. Physicians can help level the playing field.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A proportion of patients with intractable metabolic stone disease experience narcotic dependence. With careful patient selection, renal autotransplantation and pyelovesicostomy may offer resolution of chronic pain, fewer subsequent stone treatment procedures, improved quality of life and reduced daily narcotic use.
When dietary choline and L-carnitine meet gut flora, the result is TMAO — and much unhealthful mischief. New research shows the damage goes beyond atherosclerosis to heart failure, chronic kidney disease and maybe more.
Why do nephrologists feel so strongly about avoiding radical nephrectomy? Recent data suggest that the renal functional advantage of partial nephrectomy over radical nephrectomy in the setting of a normal contralateral kidney may not be as beneficial as previously believed.